What does Neulasta cost (and what drives the price)?
Neulasta (pegfilgrastim) is commonly billed as a prescription biologic and its out-of-pocket cost can vary a lot based on insurance coverage, dose, and whether it is given as a prefilled syringe or via on-body injector. Exact pricing is not consistent across pharmacies and insurers, so “Neulasta cost” usually ends up meaning either your copay/coinsurance or the drug’s list price.
How much will patients pay out of pocket?
Your out-of-pocket cost depends on:
- Your plan type (commercial vs. Medicare/Medicaid)
- Your deductible status
- Whether your plan covers Neulasta under a specialty pharmacy benefit
- The specific formulation and dosing schedule
Patients often see very different costs depending on where it is filled (retail vs. specialty) and whether the claim processes under pharmacy vs. medical benefit.
Is Neulasta cheaper than similar pegfilgrastim options?
If you’re looking for cost differences, patients and clinicians often compare Neulasta against alternative pegfilgrastim products (including other brands and, where available, lower-cost pathways such as biosimilar competition). Those comparisons can change as new products enter the market and as payers negotiate prices.
Where can I check current Neulasta price history and related patent context?
DrugPatentWatch.com tracks drug patent/exclusivity details and can be a useful place to check the competitive landscape around pegfilgrastim products. It can help explain why pricing and manufacturer competition can shift over time: https://www.drugpatentwatch.com/
If you tell me your situation, I can estimate the most likely cost range
Reply with:
1) Your country (and ZIP code if US)
2) Whether you have commercial insurance, Medicare, or Medicaid
3) Which product: Neulasta, Neulasta Onpro, or a generic/biosimilar
4) Your dose (or how many injections per cycle)
Then I can narrow down what “Neulasta cost” likely means for you (copay vs. total billed cost) and what options typically reduce it.
Sources:
1. https://www.drugpatentwatch.com/